A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine.

Ailar SabbaghiMasoud MalekSara AbdolahiSeyed Mohammad MiriLeila AlizadehMehdi SamadiSeyed Reza MohebbiAmir Ghaemi

Published in: Virology journal (2021)

The results indicate that adjuvantation with the CCL21 and poly (I:C) can successfully induce vigorous vaccine-mediated protection, suggesting a robust propensity for CCL21 plus poly (I:C) as a potent mucosal adjuvant.

Keyphrases

liver fibrosis
liver injury
early stage
drug induced
physical activity
ulcerative colitis